On ECHEMI
Home > Drugs > Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
  • Founded in:

    1992-08-21
  • Country:

    China China
  • Address:

    No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province
  • Tax NO.:

    91370000614073351Q
  • Registered Funds:

    600 million yuan
  • Website:

  • Email:

Related Drugs
Tropisetron Hydrochloride
Name Description Content CAS NO. Registered Holders
Tropisetron hydrochloride

Extract from the above information

More

Extract from the above information

105826-92-4 16
Amikacin Sulfate Injection
The main ingredient of this product is: Amikacin sulfate.
Name Description Content CAS NO. Registered Holders
Amikacin sulfate salt

Aminoglycoside antibiotics have antibacterial effects on most Enterobacteriaceae, Pseudomonas aeruginosa, some other Pseudomonas, Acinetobacter, Alcaligenes, meningococci, gonococci, influenza bacilli, Yersinia, Campylobacter fetus, Mycobacterium tuberculosis and some Mycobacterium. The mechanism of action is to act on the 30S subunit of bacterial ribosomes and inhibit bacterial protein synthesis. Combination with semi-synthetic penicillins or cephalosporins often produces synergistic antibacterial effects.

More

Aminoglycoside antibiotics have antibacterial effects on most Enterobacteriaceae, Pseudomonas aeruginosa, some other Pseudomonas, Acinetobacter, Alcaligenes, meningococci, gonococci, influenza bacilli, Yersinia, Campylobacter fetus, Mycobacterium tuberculosis and some Mycobacterium. The mechanism of action is to act on the 30S subunit of bacterial ribosomes and inhibit bacterial protein synthesis. Combination with semi-synthetic penicillins or cephalosporins often produces synergistic antibacterial effects.

149022-22-0 9
Hydroxyurea tablets
The chemical name of this product is: Hydroxyurea. Its structural formula is: Molecular formula: CH4N2O2 Molecular weight: 76.06
Name Description Content CAS NO. Registered Holders
Hydroxyurea

It is a nucleoside diphosphate reductase inhibitor that can prevent nucleotides from being reduced to deoxynucleotides, interfere with the biosynthesis of purine and pyrimidine bases, selectively inhibit DNA synthesis, and have no blocking effect on RNA and protein synthesis. It is a cycle-specific drug, and is sensitive to S-phase cells.

More

It is a nucleoside diphosphate reductase inhibitor that can prevent nucleotides from being reduced to deoxynucleotides, interfere with the biosynthesis of purine and pyrimidine bases, selectively inhibit DNA synthesis, and have no blocking effect on RNA and protein synthesis. It is a cycle-specific drug, and is sensitive to S-phase cells.

127-07-1 14
Granisetron Hydrochloride
Name Description Content CAS NO. Registered Holders
Granisetron Hydrochloride

Extract from the above information

More

Extract from the above information

107007-99-8 35
Pegylated recombinant human granulocyte-stimulating factor injection
Active ingredient: PEGylated recombinant human granulocyte-stimulating factor (PEG-rhG-CSF), obtained by cross-linking recombinant human granulocyte-stimulating factor (rhG-CSF) with 20KD polyethylene glycol and purification. Excipients: sorbitol, polysorbate 80, acetic acid-sodium acetate buffer.
Name Description Content CAS NO. Registered Holders
PEGylated recombinant human granulocyte-stimulating factor (PEG-rhG-CSF)

Granulocyte stimulating factor binds to the surface receptors of hematopoietic cells and acts on hematopoietic cells, thereby stimulating proliferation, differentiation, typing and activation of mature cell functions. Compared with rhG-CSF, PEG-rhG-CSF can reduce plasma clearance rate and prolong half-life.

More

Granulocyte stimulating factor binds to the surface receptors of hematopoietic cells and acts on hematopoietic cells, thereby stimulating proliferation, differentiation, typing and activation of mature cell functions. Compared with rhG-CSF, PEG-rhG-CSF can reduce plasma clearance rate and prolong half-life.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.